Related references
Note: Only part of the references are listed.Simultaneous Detection of Single Molecules and Singulated Ensembles of Molecules Enables Immunoassays with Broad Dynamic Range
David M. Rissin et al.
ANALYTICAL CHEMISTRY (2011)
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
J. Li et al.
NEUROLOGY (2011)
S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment
Erik Mortberg et al.
RESUSCITATION (2011)
Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
Maya A. Koike et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
David M. Rissin et al.
NATURE BIOTECHNOLOGY (2010)
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
Oskar Hansson et al.
NEUROBIOLOGY OF AGING (2010)
Homocysteine and holotranscobalamin and the risk of Alzheimer disease A longitudinal study
B. Hooshmand et al.
NEUROLOGY (2010)
The Genetics of Alzheimer Disease: Back to the Future
Lars Bertram et al.
NEURON (2010)
Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
Harry Levine
PROTEIN SCIENCE (2010)
Midlife Serum Cholesterol and Increased Risk of Alzheimer's and Vascular Dementia Three Decades Later
Alina Solomon et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Blood Pressure Components and Changes in Relation to White Matter Lesions A 32-Year Prospective Population Study
Xinxin Guo et al.
HYPERTENSION (2009)
The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
Michela Guglielmotto et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides
M Guo et al.
FEBS LETTERS (2005)
Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis
MD Kirkitadze et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
H Vanderstichele et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2000)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)